Visco Vision Inc. (TPE:6782)
Taiwan · Delayed Price · Currency is TWD 190.50
+1.50 (0.79%)
At close: Mar 13, 2026
Visco Vision Revenue
In the year 2025, Visco Vision had annual revenue of 4.22B TWD with 15.02% growth. Visco Vision had revenue of 1.07B in the quarter ending December 31, 2025, with 16.87% growth.
Revenue
4.22B
Revenue Growth
+15.02%
P/S Ratio
2.84
Revenue / Employee
n/a
Employees
n/a
Market Cap
12.00B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.22B | 551.56M | 15.02% |
| Dec 31, 2024 | 3.67B | 1.27B | 53.13% |
| Dec 31, 2023 | 2.40B | -379.85M | -13.68% |
| Dec 31, 2022 | 2.78B | 813.03M | 41.39% |
| Dec 31, 2021 | 1.96B | 438.11M | 28.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Pegavision | 7.04B |
| Formosa Optical Technology | 4.13B |
| St.Shine Optical | 4.12B |
| Vizionfocus | 3.49B |
| Pacific Hospital Supply | 2.41B |
| Nang Kuang Pharmaceutical | 2.16B |
| Bioteque | 2.14B |
| Bionime | 1.91B |